Company news
Pulse Biosciences, Inc news in 2021
Pulse Biosciences, Inc's news releases, calls and decks from 2021, newest first.
Pulse Biosciences to Participate in the Stephens Annual Investment Conference
November 17, 2021
Pulse Biosciences Reports Third Quarter 2021 Financial Results
November 14, 2021
Pulse Biosciences to Present at the Stifel 2021 Virtual Healthcare Conference
November 3, 2021
Pulse Biosciences Schedules Third Quarter 2021 Financial Results Conference Call for November 15, 2021
November 1, 2021
Pulse Biosciences Appoints Laureen DeBuono to Its Board of Directors
October 4, 2021
Pulse Biosciences to Participate in the H.C. Wainwright Global Investment Conference
September 1, 2021
Pulse Biosciences Announces Appointment of Mitchell E. Levinson as Chief Strategy Officer
August 18, 2021
Pulse Biosciences Reports Second Quarter 2021 Financial Results
August 8, 2021
Pulse Biosciences Schedules Second Quarter 2021 Financial Results Conference Call for August 9, 2021
July 25, 2021
Pulse Biosciences Announces $50 Million Private Placement
June 30, 2021
Pulse Biosciences Announces First CellFX® Procedure Performed in Canada
June 29, 2021
Pulse Biosciences Announces Health Canada Approval for CellFX® System
June 8, 2021
Pulse Biosciences to Participate in the Jefferies Healthcare Conference
May 23, 2021
Pulse Biosciences® Presents Clinical Study Results of Nano-Pulse Stimulation™ Technology to Clear Benign Lesions at the American Society for Laser Medicine and Surgery (ASLMS) 2021 Virtual Annual Conference
May 12, 2021
Pulse Biosciences Reports First Quarter 2021 Financial Results
May 9, 2021
Pulse Biosciences Schedules First Quarter 2021 Financial Results Conference Call for May 10, 2021
April 25, 2021
Pulse Biosciences to Present Consumer Research on Patient Perceptions of Benign Lesion Clearance at American Academy of Dermatology VMX Meeting 2021
April 21, 2021
Pulse Biosciences to Participate in Upcoming Investor Conferences
March 4, 2021
Pulse Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results
February 21, 2021
Pulse Biosciences Announces First CellFX Procedures Performed in Europe as Part of Global Controlled Launch
February 18, 2021
Pulse Biosciences Announces Start of Controlled Launch of the CellFX System®
February 15, 2021
Pulse Biosciences Schedules Fourth Quarter and Full Year 2020 Financial Results Conference Call for February 22, 2021
February 11, 2021
Pulse Biosciences, Inc. Announces At-The-Market Equity Offering Program
February 3, 2021
Pulse Biosciences Announces FDA Clearance for the CellFX® System
February 2, 2021
Pulse Biosciences Announces CE Mark Approval for CellFX® System
January 24, 2021
Pulse Biosciences Updates on CellFX System Regulatory and Clinical Study Progress
January 11, 2021
Pulse Biosciences, Inc. Announces Redemption of Warrants
January 4, 2021